1
Clinical Trials associated with Human Hepatitis B Immunoglubolin (Tonrol Biological)冻干静注乙型肝炎人免疫球蛋白联合拉米夫定用于预防HBV相关疾病肝移植患者术后HBV再感染的疗效和安全性临床研究
[Translation] Clinical study on the efficacy and safety of freeze-dried intravenous hepatitis B human immunoglobulin combined with lamivudine in preventing HBV reinfection in liver transplant patients with HBV-related diseases
主要目的: 评价同路生物制药股份有限公司生产的冻干静注乙型肝炎人免疫球蛋白(pH4)联合拉米夫定预防乙型肝炎病毒(HBV)相关疾病肝移植患者术后HBV再感染的临床有效性。 次要目的: 评价冻干静注乙型肝炎人免疫球蛋白(pH4)的临床安全性。
[Translation] Primary objective: To evaluate the clinical effectiveness of freeze-dried intravenous hepatitis B human immunoglobulin (pH4) produced by Tonglu Biopharmaceutical Co., Ltd. combined with lamivudine in preventing HBV reinfection after liver transplantation in patients with hepatitis B virus (HBV)-related diseases. Secondary objective: To evaluate the clinical safety of freeze-dried intravenous hepatitis B human immunoglobulin (pH4).
100 Clinical Results associated with Human Hepatitis B Immunoglubolin (Tonrol Biological)
100 Translational Medicine associated with Human Hepatitis B Immunoglubolin (Tonrol Biological)
100 Patents (Medical) associated with Human Hepatitis B Immunoglubolin (Tonrol Biological)
100 Deals associated with Human Hepatitis B Immunoglubolin (Tonrol Biological)